Pillstats
Rx only · Suppository · Rectal

Prochlorperazine

Brands: Compro · Prochlorperazine

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN05AB04
RxCUI (US)8704
US makers3 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.85$3.71$5.56$7.41Dec 2025Apr 2026Jul 2026
$5.480
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
3
Active US suppliers
80%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.1K2.3K3.4K4.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.5K
Rx · 2026 Q1
59K
Units dispensed
-7%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
PD-Rx Pharmaceuticals, Inc.unknown2SUPPLYING
Cosette Pharmaceuticals, Inc.unknown2SUPPLYING
Padagis US LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.